HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000032 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
150,000
Total Value
$4,683,156.78
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 2, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 4,100 | $69.20 | $283,707.70 | 783,680 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 15,322 | $69.80 | $1,069,460.28 | 768,358 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 578 | $70.46 | $40,726.46 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 3, 2026 | Sale | 13,481 | $68.85 | $928,166.85 | 774,299 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 3, 2026 | Sale | 6,519 | $69.33 | $451,981.83 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Exercise/Conversion | 10,000 | $12.07 | $120,700.00 | 777,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 7,329 | $69.94 | $512,619.58 | 770,451 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 2,671 | $70.94 | $189,494.09 | 767,780 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Mar 2, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 181,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Mar 3, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 161,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Mar 4, 2026 | Exercise/Conversion | 10,000 | $12.07 | $120,700.00 | 151,923 | Direct | โ | View Details |